Steven Tignor, Merck & Co., Inc. - Qepler Summits And Conferences

Steven Tignor

Senior Scientist
Merck & Co., Inc.
New York, USA
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.

Steven Tignor is a Senior Scientist in Analytical Research & Development at Merck. He received his Bachelor's Degree in Chemistry and Physics from Rensselaer Polytechnic Institute in 2016 studying material properties and degradation pathways of fuel cell materials and his Ph.D. in Chemistry from Princeton University in 2020 studying novel organometallic electrocatalysis mechanisms.

Since beginning at Merck in 2020 he has led several efforts in understanding nitrosamine formation and inhibition within drug products. His research interests range synthetic organic chemistry, analytical chemistry, and materials science. Currently, Steven is heavily involved in both drug substance and drug product development at Merck, contributing significantly to internal impurity risk assessments, CMC authoring, and regulatory interactions.

Related Sessions:

3rd Annual Genotoxic Impurities
in Pharmaceuticals Summit 2023

Genotoxic Impurities in Pharmaceuticals strategies & new methodologies: analysis, in silico & regulations.
  • 09 Mar 2023
  • Virtual,
  • Pharma
Day 1: Thursday, 09 March 2023
CASE STUDY: Inhibition of Nitrosamine Formation in Drug Products
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.